Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Sep;92(3):1477–1482. doi: 10.1172/JCI116725

Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats.

R Olivenstein 1, P M Renzi 1, J P Yang 1, P Rossi 1, S Laberge 1, S Waserman 1, J G Martin 1
PMCID: PMC288293  PMID: 8376599

Abstract

Recent evidence supports a role for T lymphocytes in allergic airway responses. We hypothesized that reducing blood T suppressor cells (Ts) might increase the late airway response (LR). Sprague-Dawley (SD) rats were sensitized with ovalbumin (OA). On days 8, 10, and 12, post-sensitization test SD (n = 14) received monoclonal antibody intravenously (OX-8; 1 mg) specific to rat Ts. Controls received saline (n = 7) or mouse ascites IgG (n = 7). On day 14, animals were challenged with OA aerosol (5% wt/vol) for 5 min, lung resistance was recorded for 8 h (n = 18) and bronchoalveolar lavage was performed. The LR was determined from the area under the lung resistance vs time curve from 75 to 480 min after challenge. In the remaining 10 rats, airway lymphocyte subsets were measured 8 h after OA aerosol challenge in minced and digested lungs. A decrease in percentage of blood and airway Ts, respectively, in test animals was observed vs controls (blood: 6.27 +/- 0.84 vs 32.95 +/- 1.94, P < 0.001); (airway: 5.05 +/- 0.66 vs 24.5 +/- 3.05, P < 0.02). Blood and airway helper T lymphocytes did not differ between test and control animals. The LR was significantly increased in test (22.89 +/- 3.92) vs controls (4.22 +/- 2.18, P < 0.001). Bronchoalveolar lavage macrophages, neutrophils and lymphocytes, and serum OA-specific IgE were also significantly elevated (P < 0.05) in test animals. We conclude that Ts play an important role in attenuating the LR in SD rats.

Full text

PDF
1477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson G. L., Colizzi V., Zembala M. An overview of T-suppressor cell circuits. Annu Rev Immunol. 1986;4:37–68. doi: 10.1146/annurev.iy.04.040186.000345. [DOI] [PubMed] [Google Scholar]
  2. Azzawi M., Bradley B., Jeffery P. K., Frew A. J., Wardlaw A. J., Knowles G., Assoufi B., Collins J. V., Durham S., Kay A. B. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1407–1413. doi: 10.1164/ajrccm/142.6_Pt_1.1407. [DOI] [PubMed] [Google Scholar]
  3. Benaroch P., Georgatsou E., Bordenave G. Cellular induction of chronic allotype suppression of IgG2a in Ighb/b homozygous mice and its abrogation by in vivo treatment with anti-CD8 monoclonal antibody. J Exp Med. 1988 Sep 1;168(3):891–904. doi: 10.1084/jem.168.3.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brideau R. J., Carter P. B., McMaster W. R., Mason D. W., Williams A. F. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol. 1980 Aug;10(8):609–615. doi: 10.1002/eji.1830100807. [DOI] [PubMed] [Google Scholar]
  5. Canonica G. W., Mingari M. C., Melioli G., Colombatti M., Moretta L. Imbalances of T cell subpopulations in patients with atopic diseases and effect of specific immunotherapy. J Immunol. 1979 Dec;123(6):2669–2672. [PubMed] [Google Scholar]
  6. Cantrell D. A., Robins R. A., Brooks C. G., Baldwin R. W. Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte subsets. Immunology. 1982 Jan;45(1):97–103. [PMC free article] [PubMed] [Google Scholar]
  7. Cartier A., Grammer L., Malo J. L., Lagier F., Ghezzo H., Harris K., Patterson R. Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol. 1989 Oct;84(4 Pt 1):507–514. doi: 10.1016/0091-6749(89)90364-3. [DOI] [PubMed] [Google Scholar]
  8. Corrigan C. J., Hartnell A., Kay A. B. T lymphocyte activation in acute severe asthma. Lancet. 1988 May 21;1(8595):1129–1132. doi: 10.1016/s0140-6736(88)91951-4. [DOI] [PubMed] [Google Scholar]
  9. Corrigan C. J., Kay A. B. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):970–977. doi: 10.1164/ajrccm/141.4_Pt_1.. [DOI] [PubMed] [Google Scholar]
  10. Damle N. K., Engleman E. G. Antigen-specific suppressor T lymphocytes in man. Clin Immunol Immunopathol. 1989 Nov;53(2 Pt 2):S17–S24. doi: 10.1016/0090-1229(89)90066-4. [DOI] [PubMed] [Google Scholar]
  11. Damle N. K., Engleman E. G. Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus. J Exp Med. 1983 Jul 1;158(1):159–173. doi: 10.1084/jem.158.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dorf M. E., Benacerraf B. Suppressor cells and immunoregulation. Annu Rev Immunol. 1984;2:127–157. doi: 10.1146/annurev.iy.02.040184.001015. [DOI] [PubMed] [Google Scholar]
  13. Eidelman D. H., Bellofiore S., Martin J. G. Late airway responses to antigen challenge in sensitized inbred rats. Am Rev Respir Dis. 1988 May;137(5):1033–1037. doi: 10.1164/ajrccm/137.5.1033. [DOI] [PubMed] [Google Scholar]
  14. Engel P., Huguet J., Sanosa J., Sierra P., Cols N., García-Calderón P. A. T cell subsets in allergic respiratory disease using monoclonal antibodies. Ann Allergy. 1984 Oct;53(4):337–340. [PubMed] [Google Scholar]
  15. Faure M. R., Gaucherand M. A., Thivolet J., Czernielewski J. M., Nicolas J. F. Decreased levels of T-cells and cells with suppressor T-cell phenotype as defined by specific monoclonal antibodies in patients with atopic dermatitis. Clin Exp Dermatol. 1982 Sep;7(5):513–518. doi: 10.1111/j.1365-2230.1982.tb02468.x. [DOI] [PubMed] [Google Scholar]
  16. Finotto S., Fabbri L. M., Rado V., Mapp C. E., Maestrelli P. Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate. Br J Ind Med. 1991 Feb;48(2):116–121. doi: 10.1136/oem.48.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Frew A. J., Kay A. B. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol. 1988 Dec 15;141(12):4158–4164. [PubMed] [Google Scholar]
  18. Gerblich A. A., Campbell A. E., Schuyler M. R. Changes in T-lymphocyte subpopulations after antigenic bronchial provocation in asthmatics. N Engl J Med. 1984 May 24;310(21):1349–1352. doi: 10.1056/NEJM198405243102103. [DOI] [PubMed] [Google Scholar]
  19. Gonzalez M. C., Diaz P., Galleguillos F. R., Ancic P., Cromwell O., Kay A. B. Allergen-induced recruitment of bronchoalveolar helper (OKT4) and suppressor (OKT8) T-cells in asthma. Relative increases in OKT8 cells in single early responders compared with those in late-phase responders. Am Rev Respir Dis. 1987 Sep;136(3):600–604. doi: 10.1164/ajrccm/136.3.600. [DOI] [PubMed] [Google Scholar]
  20. Haig D. M., McMenamin C., Redmond J., Brown D., Young I. G., Cohen S. D., Hapel A. J. Rat IL-3 stimulates the growth of rat mucosal mast cells in culture. Immunology. 1988 Oct;65(2):205–211. [PMC free article] [PubMed] [Google Scholar]
  21. Hamid Q., Azzawi M., Ying S., Moqbel R., Wardlaw A. J., Corrigan C. J., Bradley B., Durham S. R., Collins J. V., Jeffery P. K. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest. 1991 May;87(5):1541–1546. doi: 10.1172/JCI115166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Harper T. B., Gaumer H. R., Waring W., Brannon R. B., Salvaggio J. E. A comparison of cell-mediated immunity and suppressor T-cell function in asthmatic and normal children. Clin Allergy. 1980 Sep;10(5):555–563. doi: 10.1111/j.1365-2222.1980.tb02137.x. [DOI] [PubMed] [Google Scholar]
  23. Hwang K. C., Fikrig S. M., Friedman H. M., Gupta S. Deficient concanavalin-A-induced suppressor-cell activity in patients with bronchial asthma, allergic rhinitis and atopic dermatitis. Clin Allergy. 1985 Jan;15(1):67–72. doi: 10.1111/j.1365-2222.1985.tb02257.x. [DOI] [PubMed] [Google Scholar]
  24. Ilfeld D., Kivity S., Feierman E., Topilsky M., Kuperman O. Effect of in vitro colchicine and oral theophylline on suppressor cell function of asthmatic patients. Clin Exp Immunol. 1985 Aug;61(2):360–367. [PMC free article] [PubMed] [Google Scholar]
  25. Jeffery P. K., Wardlaw A. J., Nelson F. C., Collins J. V., Kay A. B. Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis. 1989 Dec;140(6):1745–1753. doi: 10.1164/ajrccm/140.6.1745. [DOI] [PubMed] [Google Scholar]
  26. Kus J., Tse K. S., Enarson D., Grzybowski S., Chan-Yeung M. Lymphocyte subpopulations in patients with allergic rhinitis. Allergy. 1984 Oct;39(7):509–514. doi: 10.1111/j.1398-9995.1984.tb00871.x. [DOI] [PubMed] [Google Scholar]
  27. Kus J., Tse K. S., Vedal S., Chan-Yeung M. Lymphocyte sub-populations in patients with allergic and non-allergic asthma. Clin Allergy. 1985 Nov;15(6):523–529. doi: 10.1111/j.1365-2222.1985.tb02305.x. [DOI] [PubMed] [Google Scholar]
  28. Leist T. P., Rüedi E., Zinkernagel R. M. Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells. J Exp Med. 1988 May 1;167(5):1749–1754. doi: 10.1084/jem.167.5.1749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Leung D. Y., Geha R. S. Regulation of the human IgE antibody response. Int Rev Immunol. 1987 Jan;2(1):75–91. doi: 10.3109/08830188709044748. [DOI] [PubMed] [Google Scholar]
  30. Like A. A., Biron C. A., Weringer E. J., Byman K., Sroczynski E., Guberski D. L. Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med. 1986 Oct 1;164(4):1145–1159. doi: 10.1084/jem.164.4.1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lopez A. F., Sanderson C. J., Gamble J. R., Campbell H. D., Young I. G., Vadas M. A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med. 1988 Jan 1;167(1):219–224. doi: 10.1084/jem.167.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Meininger C. J., Yano H., Rottapel R., Bernstein A., Zsebo K. M., Zetter B. R. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood. 1992 Feb 15;79(4):958–963. [PubMed] [Google Scholar]
  33. Metzger W. J., Zavala D., Richerson H. B., Moseley P., Iwamota P., Monick M., Sjoerdsma K., Hunninghake G. W. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am Rev Respir Dis. 1987 Feb;135(2):433–440. doi: 10.1164/arrd.1987.135.2.433. [DOI] [PubMed] [Google Scholar]
  34. Parish N. M., Roitt I. M., Cooke A. Phenotypic characteristics of cells involved in induced suppression to murine experimental autoimmune thyroiditis. Eur J Immunol. 1988 Sep;18(9):1463–1467. doi: 10.1002/eji.1830180924. [DOI] [PubMed] [Google Scholar]
  35. Phillips S. M., Linette G. P., Doughty B. L., Byram J. E., Von Lichtenberg F. In vivo T cell depletion regulates resistance and morbidity in murine schistosomiasis. J Immunol. 1987 Aug 1;139(3):919–926. [PubMed] [Google Scholar]
  36. Poznansky M. C., Gordon A. C., Grant I. W., Wyllie A. H. A cellular abnormality in glucocorticoid resistant asthma. Clin Exp Immunol. 1985 Jul;61(1):135–142. [PMC free article] [PubMed] [Google Scholar]
  37. Renzi P. M., Olivenstein R., Martin J. G. Inflammatory cell populations in the airways and parenchyma after antigen challenge in the rat. Am Rev Respir Dis. 1993 Apr;147(4):967–974. doi: 10.1164/ajrccm/147.4.967. [DOI] [PubMed] [Google Scholar]
  38. Rivlin J., Kuperman O., Freier S., Godfrey S. Suppressor T-lymphocyte activity in wheezy children with and without treatment by hyposensitization. Clin Allergy. 1981 Jul;11(4):353–356. doi: 10.1111/j.1365-2222.1981.tb01605.x. [DOI] [PubMed] [Google Scholar]
  39. Rocklin R. E., Sheffer A. L., Greineder D. K., Melmon K. L. Generation of antigen-specific suppressor cells during allergy desensitization. N Engl J Med. 1980 May 29;302(22):1213–1219. doi: 10.1056/NEJM198005293022201. [DOI] [PubMed] [Google Scholar]
  40. Rola-Pleszczynski M., Blanchard R. Suppressor cell function in respiratory allergy. Modulation by aminophylline and isoproterenol. Int Arch Allergy Appl Immunol. 1981;64(4):361–370. doi: 10.1159/000232717. [DOI] [PubMed] [Google Scholar]
  41. Sedgwick J. D. Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur J Immunol. 1988 Apr;18(4):495–502. doi: 10.1002/eji.1830180402. [DOI] [PubMed] [Google Scholar]
  42. Sorkness R., Johns K., Castleman W. L., Lemanske R. F., Jr Late pulmonary allergic responses in actively but not passively IgE-sensitized rats. J Appl Physiol (1985) 1990 Sep;69(3):1012–1021. doi: 10.1152/jappl.1990.69.3.1012. [DOI] [PubMed] [Google Scholar]
  43. Titus R. G., Ceredig R., Cerottini J. C., Louis J. A. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol. 1985 Sep;135(3):2108–2114. [PubMed] [Google Scholar]
  44. Walker C., Bode E., Boer L., Hansel T. T., Blaser K., Virchow J. C., Jr Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis. 1992 Jul;146(1):109–115. doi: 10.1164/ajrccm/146.1.109. [DOI] [PubMed] [Google Scholar]
  45. Walsh G. M., Hartnell A., Wardlaw A. J., Kurihara K., Sanderson C. J., Kay A. B. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology. 1990 Oct;71(2):258–265. [PMC free article] [PubMed] [Google Scholar]
  46. Waserman S., Olivenstein R., Renzi P., Xu L. J., Martin J. G. The relationship between late asthmatic responses and antigen-specific immunoglobulin. J Allergy Clin Immunol. 1992 Oct;90(4 Pt 1):661–669. doi: 10.1016/0091-6749(92)90140-w. [DOI] [PubMed] [Google Scholar]
  47. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med. 1988 May 1;167(5):1737–1742. doi: 10.1084/jem.167.5.1737. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES